Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.jbpharma.com | |
Market Cap | 23,048.86 Cr. | |
Enterprise Value(EV) | 22,987.40 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 31.39 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 47.36 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.71 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 175.22 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 8.48 | Calculated using Price: 1,486.60 |
Dividend Yield | 0.60 | Period Ending 2023-03 |
No. of Shares Subscribed | 15.50 Cr. | 155,044,160 Shares |
FaceValue | 1 | |
About JB Chemicals & Pharmaceuticals Ltd. | ||
J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs. JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL. |
1 Day |
|
+0.68% |
1 Week |
|
+6.69% |
1 Month |
|
+5.94% |
3 Month |
|
+5.81% |
6 Month |
|
+40.25% |
1 Year |
|
+47.17% |
2 Year |
|
+84.03% |
5 Year |
|
+883.78% |
10 Year |
|
+2548.84% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 9.86 | 14.93 | 14.48 | 9.89 | 13.28 | 18.69 | 27.64 | 19.89 | 18.51 | |
Return on Capital Employed (%) | 13.49 | 17.83 | 16.87 | 13.70 | 19.59 | 23.71 | 36.53 | 25.48 | 22.79 | |
Return on Assets (%) | 7.08 | 9.29 | 8.99 | 6.43 | 8.52 | 12.53 | 19.55 | 13.69 | 11.44 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 995 | 1,184 | 1,364 | 1,442 | 1,480 | 1,435 | 1,810 | 2,134 | 2,480 | 2,717 | |
Non Curr. Liab. | 33 | 31 | 27 | 46 | 65 | 63 | 72 | 475 | 992 | 434 | |
Curr. Liab. | 460 | 797 | 693 | 737 | 782 | 516 | 687 | 455 | 626 | 643 | |
Minority Int. | 2 | 2 | 3 | 3 | 3 | 4 | 4 | ||||
Equity & Liab. | 1,487 | 2,014 | 2,086 | 2,226 | 2,329 | 2,017 | 2,572 | 3,069 | 4,098 | 3,794 | |
Non Curr. Assets | 586 | 832 | 879 | 718 | 741 | 741 | 679 | 1,745 | 2,499 | 2,036 | |
Curr. Assets | 901 | 1,182 | 1,207 | 1,509 | 1,589 | 1,276 | 1,894 | 1,325 | 1,599 | 1,758 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,487 | 2,014 | 2,086 | 2,226 | 2,329 | 2,017 | 2,572 | 3,069 | 4,098 | 3,794 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1,144 | 1,232 | 1,368 | 1,414 | 1,643 | 1,775 | 2,043 | 2,424 | 3,149 | 3,333 | |
Other Income | 11 | 57 | 54 | 55 | 41 | 51 | 117 | 40 | 10 | 21 | |
Total Income | 1,155 | 1,288 | 1,422 | 1,469 | 1,685 | 1,826 | 2,159 | 2,464 | 3,159 | 3,354 | |
Total Expenditure | -964 | -1,026 | -1,140 | -1,215 | -1,337 | -1,397 | -1,486 | -1,882 | -2,454 | -2,519 | |
PBIDT | 191 | 263 | 283 | 254 | 347 | 428 | 673 | 583 | 706 | 835 | |
Interest | -7 | -11 | -5 | -3 | -5 | -3 | -7 | -5 | -36 | -45 | |
Depreciation | -39 | -41 | -47 | -57 | -56 | -66 | -69 | -73 | -114 | -124 | |
Taxation | -45 | -50 | -46 | -55 | -93 | -77 | -148 | -119 | -145 | -180 | |
Exceptional Items | -10 | ||||||||||
PAT | 100 | 163 | 184 | 139 | 194 | 272 | 449 | 386 | 410 | 487 | |
Minority Interest | 0 | 0 | 0 | -1 | 0 | -1 | -1 | 0 | |||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 100 | 163 | 184 | 138 | 193 | 272 | 448 | 385 | 410 | 487 | |
Adjusted EPS | 6 | 10 | 11 | 8 | 12 | 18 | 29 | 25 | 26 | 31 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -14 | 127 | 140 | 201 | 123 | 194 | 276 | 315 | 170 | 626 | |
Cash Fr. Inv. | -143 | -112 | -28 | -45 | -21 | -28 | 24 | -231 | 2 | -962 | |
Cash Fr. Finan. | 12 | -1 | -100 | -184 | -60 | -156 | -306 | -87 | -138 | 357 | |
Net Change | -144 | 13 | 13 | -28 | 43 | 11 | -6 | -3 | 34 | 20 | |
Cash & Cash Eqvt | 12 | 25 | 9 | -21 | 21 | 32 | 26 | 22 | 57 | 77 |
Tue, 05 Dec 2023
Resignation
|
|
Fri, 01 Dec 2023
ESOP/ESOS/ESPS
|
|
Fri, 01 Dec 2023
Alteration Of Capital and Fund Raising-XBRL
|
Tue, 05 Dec 2023 |
|
|
|
|
|